Chowdhury SD,Oommen AM .2020 .. Epidemiology of COVID19. J Dig Endosc, 11 : 3-7.
Ruslie RH,Darmadi D.,Coronavirus D. .2020 .-19 and mental health. Open Access Maced J Med Sci, 8 : 268-71.
Siregar GA,Siregar GP,Darmadi D,Ruslie RH,Injury Liver .2020 .. Open Access Maced J Med Sci, 8 : 154-7.
Siregar GA,Siregar GP,Darmadi D,Review A .2020 .. Open Access Maced J Med Sci, 8 : 52-4.
Ruslie RH,Darmadi D,Siregar GA .2020 .Paediatric immunization practice during coronavirus disease-2019 pandemic. Open Access Maced J Med Sci, 8 : 258-60.
Ruslie RH,Darmadi D,Siregar GA .2020 .Susceptibility of coronavirus disease-19 in pediatric population. Open Access Maced J Med Sci, 8 : 363-5.
.2023 .WHO Coronavirus (COVID-19) Dashboard. , : .
- ,- .2023 .The National Institute for Health and Care Excellence (NICE. COVID-19 Rapid Guideline: Managing COVID19, : .
Bronte V,Ugel S,Tinazzi E,Vella A,De Sanctis F,Canè S .2020 .Baricitinib restrains the immune dysregulation in patients with severe COVID-19. J Clin Invest, 130 : 6409-16.
Petrone L,Petruccioli E,Alonzi T,Vanini V,Cuzzi G,Fard SN .2021 .In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy. J Infect, 82 : 58-66.
Sims JT,Krishnan V,Chang CY,Engle SM,Casalini G,Rodgers GH .2021 .Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19. J Aller Clin Immunol, 147 : 107-11.
Kalil AC,Patterson TF,Mehta AK,Tomashek KM,Wolfe CR,Ghazaryan V .2021 .Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N Engl J Med, 384 : 795-807.
Chen C-X,Wang J-J,Li H,Yuan L-T RP,Liang Y. .2021 .JAK-Inhibitors for Coronavirus Disease-2019 (COVID19): A Meta-analysis. Leukemia, 35 : 2616-20.
Selvaraj V,Finn A,Lal A,Khan MS,Dapaah-Afriyie K,Carino GP .2022 .Baricitinib in Hospitalised Patients with COVID-19: A Meta-analysis of Randomized Controlled Trials. Clin Med, 49 : 101489.
Zhang X,Shang L,Fan G,Gu X,Xu J,Wang Y .2022 .The Efficacy and Safety of Janus Kinase Inhibitors for Patients With COVID-19: A Living Systematic Review and MetaAnalysis. Front Med, 8 : 800492.
Limen RY,Sedono R,Sugiarto A,Hariyanto TI .2012 .Janus Kinase (JAK)-Inhibitors and Coronavirus Disease 2019 (Covid-19) Outcomes: A Systematic Review and Metaanalysis. Expert Rev Anti Infect Ther, : 1-10.
Lin Z,Niu J,Xu Y,Qin L,Ding J,Zhou L. .2022 .Clinical Efficacy and Adverse Events of Baricitinib Treatment for Coronavirus Disease‐2019 (COVID‐19): A Systematic Review and Meta‐analysis. J Med Virol, 94 : 1523-34.
Ely EW,Ramanan AV,Kartman CE,de Bono S,Liao R,Piruzeli MLB .2022 .Efficacy and Safety of Baricitinib Plus Standard of Care for The Treatment of Critically Ill Hospitalised Adults with COVID-19 on Invasive Mechanical Ventilation or Extracorporeal Membrane Oxygenation: An Exploratory, Randomised, Placebocontrolled Trial. Lancet Respir Med, 10 : 327-36.
Wong CKH,Lau KTK,Au ICH,Xiong X,Chung MSH,Leung BYC .2022 .Initiation of Tocilizumab or Baricitinib Were Associated with Comparable Clinical Outcomes Among Patients Hospitalized with COVID-19 and Treated with Dexamethasone. Front Pharmacol, 13 : 866441.
Roddy J,Wells D,Schenck K,Santosh S,Santosh S. Tocilizumab .2022 .Versus Baricitinib in Patients Hospitalized With COVID-19 Pneumonia and Hypoxemia: A Multicenter Retrospective Cohort Study. Crit Care Explor, 4 : e0702.
Rodriguez-Garcia JL,Sanchez-Nievas G,ArevaloSerrano J,Garcia-Gomez C,Jimenez-Vizuete JM,Martinez-Alfaro E. Baricitinib JM .2021 .Improves Respiratory Function in Patients Treated with Corticosteroids for SARS-CoV-2 Pneumonia: An Observational Cohort Study. Rheumatology, 60 : 399-407.
So JM,Umeh C,Noriega S,Stratton E,Aseri M,Gupta RC .2021 .Use of Baricitinib in Combination with Remdesivir and Steroid in COVID-19 Treatment: A Multicenter Retrospective Study. Cureus, 13 : e20620.
Russo A,Grimaldi P,Pisaturo M,Onorato L,Coppola N. .2024 .Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data. Front Immunol, 15 : 1295029.
Maher MC,Soriaga LB,Gupta A,Chen YP,di Iulio J,Ledoux S .2022 .Antibody therapy reverses biological signatures of COVID-19 progression. Cell Rep Med, : 3.